Recent animal experiments with metrizamide (Amipaque) in the subarachnoid space have essentially substantiated the low toxicity previously demonstrated. The interaction with neuroleptic drugs has been confirmed. Whether clinical doses of metrizamide may induce adhesive arachnoiditis is still unsettled.